Literature DB >> 32286153

LARP1 isoform expression in human cancer cell lines.

Hagen Schwenzer1, Mai Abdel Mouti1, Pia Neubert1, Josephine Morris1, Joanne Stockton2, Sarah Bonham3, Martin Fellermeyer1, James Chettle1, Roman Fischer3, Andrew D Beggs2, Sarah P Blagden1.   

Abstract

LARP1 is an oncogenic RNA-binding protein required for ribosome biogenesis and cancer cell survival. From published in vitro studies, there is disparity over which of two different LARP1 protein isoforms (termed the long LI-LARP1 and short SI-LARP1) is the canonical. Here, after conducting a series of biochemical and cellular assays, we conclude that LI-LARP1 (NM_033551.3 > NP_056130.2) is the dominantly expressed form. We observe that SI-LARP1 (NM_015315.5> NP_056130.2) is epigenetically repressed and that this repression is evolutionarily conserved in all but a small subclade of mammalian species. As with other LARP family members, there are multiple potential LARP1 mRNA isoforms that appear to be censored within the nucleus. The capacity of the cell to modulate splicing and expression of these apparently 'redundant' mRNAs hints at contextually specific mechanisms of LARP1 expression.

Entities:  

Keywords:  LARP1; RNA Binding Proteins; alternative protein isoforms; cancer

Year:  2020        PMID: 32286153      PMCID: PMC7928056          DOI: 10.1080/15476286.2020.1744320

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  43 in total

1.  A genomic view of alternative splicing.

Authors:  Barmak Modrek; Christopher Lee
Journal:  Nat Genet       Date:  2002-01       Impact factor: 38.330

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  The human genome browser at UCSC.

Authors:  W James Kent; Charles W Sugnet; Terrence S Furey; Krishna M Roskin; Tom H Pringle; Alan M Zahler; David Haussler
Journal:  Genome Res       Date:  2002-06       Impact factor: 9.043

4.  Histone H3K27ac separates active from poised enhancers and predicts developmental state.

Authors:  Menno P Creyghton; Albert W Cheng; G Grant Welstead; Tristan Kooistra; Bryce W Carey; Eveline J Steine; Jacob Hanna; Michael A Lodato; Garrett M Frampton; Phillip A Sharp; Laurie A Boyer; Richard A Young; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-24       Impact factor: 11.205

Review 5.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

6.  La-related Protein 1 (LARP1) Represses Terminal Oligopyrimidine (TOP) mRNA Translation Downstream of mTOR Complex 1 (mTORC1).

Authors:  Bruno D Fonseca; Chadi Zakaria; Jian-Jun Jia; Tyson E Graber; Yuri Svitkin; Soroush Tahmasebi; Danielle Healy; Huy-Dung Hoang; Jacob M Jensen; Ilo T Diao; Alexandre Lussier; Christopher Dajadian; Niranjan Padmanabhan; Walter Wang; Edna Matta-Camacho; Jaclyn Hearnden; Ewan M Smith; Yoshinori Tsukumo; Akiko Yanagiya; Masahiro Morita; Emmanuel Petroulakis; Jose L González; Greco Hernández; Tommy Alain; Christian K Damgaard
Journal:  J Biol Chem       Date:  2015-05-04       Impact factor: 5.157

7.  A Pan-cancer Transcriptome Analysis Reveals Pervasive Regulation through Alternative Promoters.

Authors:  Deniz Demircioğlu; Engin Cukuroglu; Martin Kindermans; Tannistha Nandi; Claudia Calabrese; Nuno A Fonseca; André Kahles; Kjong-Van Lehmann; Oliver Stegle; Alvis Brazma; Angela N Brooks; Gunnar Rätsch; Patrick Tan; Jonathan Göke
Journal:  Cell       Date:  2019-09-05       Impact factor: 41.582

Review 8.  Alternative Splicing May Not Be the Key to Proteome Complexity.

Authors:  Michael L Tress; Federico Abascal; Alfonso Valencia
Journal:  Trends Biochem Sci       Date:  2016-10-03       Impact factor: 13.807

Review 9.  Alternative Splicing Regulatory Networks: Functions, Mechanisms, and Evolution.

Authors:  Jernej Ule; Benjamin J Blencowe
Journal:  Mol Cell       Date:  2019-10-17       Impact factor: 17.970

Review 10.  Alternative splicing of intrinsically disordered regions and rewiring of protein interactions.

Authors:  Marija Buljan; Guilhem Chalancon; A Keith Dunker; Alex Bateman; S Balaji; Monika Fuxreiter; M Madan Babu
Journal:  Curr Opin Struct Biol       Date:  2013-05-22       Impact factor: 6.809

View more
  4 in total

Review 1.  LARP1 and LARP4: up close with PABP for mRNA 3' poly(A) protection and stabilization.

Authors:  Sandy Mattijssen; Guennadi Kozlov; Bruno D Fonseca; Kalle Gehring; Richard J Maraia
Journal:  RNA Biol       Date:  2021-01-31       Impact factor: 4.652

2.  Upregulation of 5'-terminal oligopyrimidine mRNA translation upon loss of the ARF tumor suppressor.

Authors:  Kyle A Cottrell; Ryan C Chiou; Jason D Weber
Journal:  Sci Rep       Date:  2020-12-17       Impact factor: 4.379

3.  The chromatin insulator CTCF regulates HPV18 transcript splicing and differentiation-dependent late gene expression.

Authors:  Jack Ferguson; Karen Campos-León; Ieisha Pentland; Joanne D Stockton; Thomas Günther; Andrew D Beggs; Adam Grundhoff; Sally Roberts; Boris Noyvert; Joanna L Parish
Journal:  PLoS Pathog       Date:  2021-11-04       Impact factor: 6.823

Review 4.  Alternative Splicing, Epigenetic Modifications and Cancer: A Dangerous Triangle, or a Hopeful One?

Authors:  Francisco Gimeno-Valiente; Gerardo López-Rodas; Josefa Castillo; Luis Franco
Journal:  Cancers (Basel)       Date:  2022-01-22       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.